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 ■ INTRODUCTION
Spondyloarthritis is an inflammatory disease that can affect the 
axial and peripheral skeleton. It has been shown that early diagnosis 
of this disease is difficult because of low specificity and fluctuating 
symptoms (1). Ankylosing spondylitis (AS) is the main type of 
spondyloarthritic disease (2). A Brazilian multicenter study with 1,505 
spondyloarthritis patients showed that 65.4% of patients had AS (3).
Enthesitis is inflammation of the enthesis, which is the site where 
the tendons or ligaments insert into the bone (4), and it is considered 
the hallmark of spondyloarthritis (5,6). Enthesitis often occurs in the 
lower limbs, which can lead to structural damage, such as tendon 
injury, enthesophyte formation and dysfunction. Enthesophyte 
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formation is considered a late finding of spondyloarthritis and 
chronic enthesitis (7). However, some authors have demonstrated a 
high prevalence of subclinical enthesitis using ultrasound (US) (8,9).
Complementary tests can help to diagnose and monitor patients. 
Currently, conventional radiography is still widely used as part of 
the classical classification criteria for spondyloarthritis, the modified 
New York criteria (10) and the Assessment of SpondyloArthritis 
International Society (ASAS) Group criteria (11). However, 
radiography has low sensitivity for initial inflammatory changes 
compared with magnetic resonance imaging (MRI) and US (12). 
MRI is a more sensitive method than radiography and tomography 
because this modality can be used to visualize bone edema before 
radiographic changes occur (13); however, this is a high-cost and 
low-availability method when compared with US (14). Because 
of the delay in the onset of radiographic lesions, a delay of up to 
7 years in the diagnosis of spondyloarthritis can occur (15).
Many authors have demonstrated the superiority of US in 
relation to clinical examinations for detecting changes in entheses 
(8,16,17). Some authors have noted that the agreement for detecting 
changes between power Doppler (PD) US (PDUS) and MRI is at 
least good (18,19) and that the rates and interobserver agreement of 
US are good and high for evaluating hypoechogenicity, thickening, 
calcification, enthesophyte formation, bone erosion, and PD (20).
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PD is a complementary tool to US that is used with grayscale 
to increase the sensitivity for detecting inflammatory changes 
(16,17). Despite evidence supporting the use of PDUS for the 
diagnosis of subclinical inflammation (8,16,17) and follow-up 
treatment of patients with spondyloarthritis (21), there is still a 
lack of standardized definitions of enthesitis and ultrasonographic 
parameters, which may contribute to failures in studies and make 
data comparisons difficult (1).
Few studies involving healthy participants have been published in 
this context. We believe that comparison of US findings from patients 
with inflammatory disease and healthy control individuals can help to 
identify aspects of the disease, which could help in diagnosis.
The aim of this study was to compare US findings of entheses 
between patients with AS and healthy controls based on the Madrid 
Sonographic Enthesitis Index (MASEI) (17) and to assess the 
ability of US to identify aspects related to AS.
 ■ MATERIALS AND METHODS
A cross-sectional study involving 50 AS patients classified 
by the modified New York criteria (10) or ASAS criteria (11) and 
30 healthy individuals was performed. Patients were recruited 
from rheumatology outpatient clinics at the university, and the 
healthy participants were blood donors from the blood bank of 
the institution or university staff, family, and friends. Individuals 
with a history of litigation, uncontrolled fibromyalgia, intraarticular 
corticosteroid injections in the last 3 months, previous surgery 
involving the studied structure, peripheral neuropathy, diabetes 
mellitus, hypothyroidism and venous insufficiency of the lower 
limbs with edema and/or ochre dermatitis were excluded.
Clinical Assessment
Healthy control individuals completed a questionnaire with 
demographic data, such as weight, height, and age, and they 
underwent a US evaluation. For patients with AS, apart from the US 
assessment, a clinical evaluation was performed by a rheumatologist 
who was “blinded” to the ultrasonographic findings. The assessment 
consisted of the use of a visual analog scale (VAS; from 0–10 cm) for 
evaluating pain and swelling, physician and patient global assessment, 
history of medication use and doses, and analysis of the erythrocyte 
sedimentation rate (ESR) during the first hour. The rheumatologist 
also administered the following questionnaires regarding disease 
and clinical indices: the clinical index of peripheral enthesitis from 
the Spondyloarthritis Research Consortium of Canada (SPARCC) 
(22); a disease activity index developed by the ASAS using the ESR 
(ASDAS-ESR) (23); and the Bath Ankylosing Spondylitis Disease 
Activity Index (BASDAI) (24). Other questionnaires pertaining to 
functionality and metrology (questionnaires validated for Portuguese) 
included the Bath Ankylosing Spondylitis Functional Index (BASFI) 
(25), Bath Ankylosing Spondylitis Metrology Index (BASMI) (26) 
and Health Assessment Questionnaire for Spondyloarthropathies 
(HAQ-S) (27).
US Assessment
Two radiologists with 10 years of experience conducting 
musculoskeletal US examinations performed these assessments and 
were “blinded” to the group of the participants and their clinical 
assessment findings. A MyLab60 Xvision (Esaote Biomedica, 
Genova, Italy) equipped with a linear transducer with a frequency 
of 6–18 MHz was used. The following entheses were assessed 
bilaterally: brachial triceps, distal quadriceps, proximal patellar 
tendon (in the lower pole of the patella), distal patellar tendon (tibial 
tuberosity), calcaneal tendon, and plantar fascia. Fifty patients and 
30 healthy control subjects underwent US examinations, for a total 
of 160 entheses analyzed at each site.
The US assessment of the enthesitis was based on the MASEI 
(17), which assesses the presence of calcification or ossification, 
bursitis, bone erosion, PD signal, pathologic structural change 
and thickening of the tendon at the site of insertion. Calcification 
was graded from 0–3: 1, small calcification or ossification with 
an irregularity in cortical bone; 2, clear presence of enthesophyte 
formation (hyperechoic spurs forming at a tendon insertion 
into bone and growing in the direction of the natural pull of the 
tendon involved), or medium-sized calcifications or ossifications; 
and 3, large calcifications or ossifications. Bursitis was defined 
as an area compatible with the site of a bursa with hypoechoic or 
anechoic contents that were compressible with the transducer at the 
calcaneal and distal patellar entheses. Bone erosion was defined 
as cortical breakage with bone contour defects in 2 perpendicular 
planes. PD signal indicates flow with capture of small vessels 
using a repeated pulse frequency of 500 Hz, and the gain was the 
largest possible after removal of artifacts. Pathologic structural 
change occurred if there was loss of a fibrillar pattern, hypoechoic 
appearance or fusiform thickening. Thickening of the tendon 
insertion was determined with the use of the following measures: 
brachial triceps greater than 4.3 mm, quadriceps greater than 
6.1 mm, patellar tendon greater than 4.0 mm, calcaneus greater than 
5.29 mm, and plantar fascia greater than 4.4 mm (Figure 1) (17).
The images obtained by one of the radiologists were recorded, 
and analysis of interobserver agreement was performed at a 
different time by another ultrasonographer in 10% of the total 
patient sample.
Statistical Analysis
For statistical analysis, we used SPSS for Windows (version 
17.0). Numerical data are described as the mean and standard 
deviation. Student’s t-test was applied to compare numerical 
parametric variables. The Mann–Whitney test was applied to 
compare numerical nonparametric variables. The χ2 test was used to 
compare categorical variables between groups. Logistic regression 
analysis was used to calculate the odds ratios (ORs) between 
groups. Receiver operating characteristic (ROC) curve analysis 
was used to identify individuals with AS. To analyze interobserver 
agreement, we used the Cohen Kappa (κ) coefficient of concordance 
for categorical data and the intraclass correlation coefficient (ICC) 
for continuous data with a 95% confidence interval (95% CI). 
Statistical significance was considered at 5% (p<0.05).
Ethics
The study was approved by the Ethics Committee of the 
institution, Universidade Federal de São Paulo – UNIFESP – 
Hospital São Paulo (submission number 1649/09), and was 
performed in accordance with the Helsinki Declaration of 1975, 
which was revised in 1983. All participants were between 18 and 65 
years of age, and they signed an informed consent form.
 ■ RESULTS
The average age of patients in the AS group (ASG) was slightly 
higher than that in the control group (CG). There was no significant 
difference in the demographic data, such as weight, height, body 
mass index and gender, between the groups (Table 1).
Patients in the ASG were assessed regarding related disease 
characteristics (Table 1) and drugs used (Table 2). The mean 
3Ultrasound of entheses in ankylosing spondylitis
Ishida SN et al.
CLINICS 2019;74:e727
Table 1 - Demographic and clinical characteristics of the sample.
ASG
N=50
CG
N=30
p
Age (y) – mean (SD) 43.44 (9.91) 38.70 (8.52) 0.032*
Gender 0.724**
M - n (%) 40 (80.00) 23 (76.70)
F – n (%) 10 (20.00) 7 (23.3)
Weight (kg) – mean (SD) 71.89 (15.38) 75.35 (14.30) 0.413***
Height (m) – mean (SD) 1.66 (0.09) 1.68 (0.079) 0.348*
BMI 25.20 (4.93) 26.92 (10.01) 0.358***
MASEI – mean (SD) 16.32 (11.22) 10.70 (5.27) 0.063***
Disease duration (y) 11.11 (6.76) - -
Patient Global Assessment – VAS 0–10 cm 4.46 (2.55) - -
Physician Global Assessment – VAS 0–10 cm 3.22 (1.91) - -
BASDAI 3.19 (2.10) - -
BASFI 4.27 (2.67) - -
BASMI 4.74 (2.35) - -
HAQ-S 0.57 (0.49) - -
ASDAS-ESR 2.37 (0.99) - -
SPARCC 2.80 (3.87) - -
MASEI 16.32 (11.22) - -
ESR (mm) 19.94 (16.57) - -
ASG: ankylosing spondylitis group; CG: control group; Y: years; M: male; F: female; BMI: body mass index; VAS: visual analog scale; BASDAI: Bath Ankylosing 
Spondylitis Disease Activity Index; BASFI: Bath Ankylosing Spondylitis Functional Index; BASMI: Bath Ankylosing Spondylitis Metrology Index; HAQ-S: 
Health Assessment Questionnaire for Spondyloarthropathies; ASDAS-ESR: disease activity index developed by the Assessment of SpondyloArthritis 
International Society (using the ESR); SPARCC: Clinical index of peripheral enthesitis from the Spondyloarthritis Research Consortium of Canada; MASEI: 
Madrid Sonographic Enthesis Index; ESR: erythrocyte sedimentation rate in the first hour.
* Student’s t-test; ** χ2 test; *** Mann–Whitney test.
A: Normal aspect of the calcaneal enthesis. B: Bone irregularities and calcification. C: Enthesophyte formation (*) and loss of the fibrillar pattern of the 
calcaneal tendon (arrow). D: Bone erosion with PD signal (arrow) and thickening of the tendon (bar).
Figure 1 - Ultrasound images of the calcaneal enthesis.
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duration of the disease was 11.11 (±6.76) years, showing 
long-standing disease. An estimated 26% of patients were receiving 
continuous treatment with nonsteroidal anti-inflammatory drugs 
(NSAIDs), and 50% were receiving immunobiological treatment 
with antitumor necrosis factor-alpha (anti-TNFα) drugs.
The average BASDAI score was 3.19 (±2.10), showing that 
the studied population was below the index of intense activity 
(<4). Regarding dysfunction, the BASFI index and HAQ-S 
showed moderate dysfunction with values of 4.27 (±2.67) and 
0.57 (±0.49), respectively. The ESRs ranged widely, from 1 mm 
to 82 mm, and the average was 19.94 (±16.57) mm. The mean 
ASDAS-ESR was 2.37 (±0.99), indicating moderate to high 
disease activity (23) (Table 1).
US comparisons were performed in 100 entheses of patients in 
the ASG and in 60 entheses of patients in the CG at six different 
sites (Table 3). A total of 960 entheses were assessed in this study. 
US parameters that showed significant differences between the 
groups, with worse scores in the ASG with regard to bone erosion 
in the calcaneal enthesis (p<0.001), bone erosion of the plantar 
fascia (p=0.046), thickening of the plantar fascia (p=0.002), and 
calcification of the distal quadriceps (p=0.001).
The logistic regression analysis identified the odds of belonging 
to the ASG from two US measurements. Regarding thickening of 
the plantar fascia, logistic regression analysis showed an OR of 3.47 
(p=0.003) in the ASG (Table 3). A significant difference was also 
observed between groups, with worse scores for the ASG than for 
the CG for the presence of calcification in the quadriceps enthesis 
(p=0.001), with an OR of 5.26 (p<0.001).
The average total MASEI score was not different between 
groups (ASG, 16.32±11.22 vs. CG, 10.70 ±8.52; p=0.063). The 
area under the ROC curve (AUC) was not able to determine the 
accuracy of the total MASEI score for predicting the diagnosis of 
enthesitis by AS (0.625±0.062; p=0.064).
Interobserver agreement for quantitative data regarding 
tendon thickness was excellent for all tendons, ranging from 
0.968 for the triceps (95% CI, 0.909–0.989) to 0.990 for the 
calcaneus by the ICC (28) (95% CI, 0.970–0.997) (Table 4). In the 
semiquantitative analysis, the level of agreement among the raters 
for bursitis, erosions, and PD was 100% (κ=1.00). Regarding 
calcification, the triceps yielded the lowest value (0.75), showing 
good agreement; for the other tendons, agreement was excellent, 
ranging from 0.89 (quadriceps) to 1.00. Structural changes 
showed 100% agreement in the analysis of tendons, except for 
the quadriceps, which was weak (κ=0.385). For tendon thickness, 
the κ index ranged from moderate agreement for the triceps 
(κ=0.600) to excellent agreement for the quadriceps and plantar 
fascia (95% CI, 0.818–1.00) (Table 5).
 ■ DISCUSSION
US in rheumatology has been widely used in recent decades to 
aid in the diagnosis and follow-up treatment of rheumatic diseases, 
given the greater sensitivity of US than clinical examination 
(8,9,16,17).
In our study, the comparison between findings on US for 
enthesitis in patients with diagnosed AS and healthy control 
participants was significantly different in the analysis for bone 
erosions in the calcaneal tendon enthesis (p<0.001) and in the plantar 
fascia (p=0.046), for thickening of the plantar fascia (p=0.002), and 
for calcification in the quadriceps femoris (p=0.001). According to 
logistic regression analysis, it was possible to calculate the OR for 
belonging to the ASG for plantar fascial thickening (a value of 3.47) 
and for enthesophyte formation and calcification in the quadriceps 
femoris (OR=5.26).
A high frequency of enthesitis of the lower limbs was found, 
especially in the calcaneus and plantar fascia, reinforcing previous 
findings (8,16,17). The sites of the enthesitis associated with 
spondyloarthritis that were most affected by changes on US in 
these previous studies were the calcaneal tendon and plantar fascia, 
which were the same as those that were altered in this study.
According to de Miguel et al. (17), a comparison of patients with 
spondyloarthritis or AS with healthy subjects showed a significant 
difference in MASEI scores between the groups. Although we 
studied a larger number of participants, the difference between the 
mean MASEI scores was not statistically significant between our 
groups. This result may be due to a very large difference between 
Table 2 - Drugs used in the Ankylosing Spondylitis Group.
N (%) Minimum Maximum Mean Standard Deviation
TI
M
E 
O
F 
U
SE
NSAIDs (mo) 13 (26) 1.00 180.00 35.69 55.59
Corticosteroids (mo) 1 (2) 6.00 6.00 6.00 -
Methotrexate (mo) 6 (12) 1.00 120.00 38.33 47.93
Sulfasalazine (mo) 6 (12) 2.00 120.00 31.83 44.92
Infliximab (mo) 10 (20) 12.00 72.00 39.30 19.72
Etanercept (mo) 13 (26) 2.00 36.00 17.61 13.20
Adalimumab (mo) 2 (4) 24.00 48.00 36.00 16.97
Joint injections (n) 21 (84) 0.00 3.00 0.70 0.93
D
O
SA
G
E
Diclofenac (mg/day) 2 (4) 100.00 100.00 100.00 -
Nimesulide (mg/day) 1 (2) 200.00 200.00 200.00 -
Naproxen (mg/day) 6 (12) 500.00 1,500.00 958.33 332.29
Indomethacin (mg/day) 4 (8) 50.00 100.00 81.25 23.93
Methotrexate (mg/wk) 6 (12) 12.50 20.00 16.66 3.76
Sulfasalazine (mg/day) 6 (12) 1,000.00 3,000.00 1,583.00 735.98
Prednisolone (mg/day) 1 (2) 5.00 5.00 5.00 -
mo: months; NSAID: Nonsteroidal anti-inflammatory drug; wk: weeks.
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Table 3 - Comparison of ultrasonographic findings of the entheses between groups.
Enthesis
ASG N=100
n (%)
CG N=60
n (%)
p (χ2) OR
Calcaneal (Achilles) tendon
Calcification 0.097
0 52 (52) 30 (50.0)
1 13 (13) 6 (10.0)
2 25 (25) 23 (38.3)
3 10 (10) 1 (1.7)
Bursitis 10 (10) 5 (8.3) 0.787
Erosion 17 (17) 0 <0.001
Power Doppler signal 6 (6) 0 0.084
Thickening 36 (36) 15 (25.0) 0.148
Structural change 17 (17) 5 (8.3) 0.123
Plantar fascia
Calcification 0.296
0 69 (69) 44 (73.3)
1 12 (12) 3 (5.0)
2 17 (17) 13 (21.7)
3 2 (2) 0
Erosion 7 (7) 0 0.040
Power Doppler signal 0 0  1.000
Thickening 38 (38) 9 (15.0) 0.002 3.473 (0.003)
Structural change 27 (27) 10 (16.7) 0.133
Proximal patellar tendon
Calcification 0.470
0 95 (95) 59 (98.3)
1 3 (3) 1 (1.7)
2 2 (2) 0
3 0 0
Erosion 0 0 1.000
Power Doppler signal 0 0 1.000
Thickening 61 (61) 33 (55) 0.455
Structural change 3 (3) 3 (5.0) 0.519
Distal patellar tendon
Calcification 0.822
0 88 (88) 52 (86.7)
1 9 (9) 6 (10.0)
2 2 (2) 2 (3.3)
3 1 (1) 0
Bursitis 6 (6) 2 (3.3) 0.711
Erosion 2 (2) 0 0.528
Power Doppler signal 1 (1) 0 1.000
Thickening 69 (69) 37 (61.7) 0.342
Structural change 8 (8) 9 (15.0) 0.164
Quadriceps femoralis tendon
Calcification 0.001 5.262 (0.000)
0 59 (59) 53 (88.3)
1 14 (14) 3 (5.0)
2 16 (16) 4 (6.75)
3 11 (11) 0
Erosion 2 (2) 0 0.528
Power Doppler signal 1 (1) 0 1.000
Thickening 45 (45) 23 (38.3) 0.409
Structural change 14 (14) 6 (10.0) 0.459
Continue...
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the disease duration of our patients, ranging from 1.5–40 years 
of disease. The inclusion of patients with early and long-standing 
disease could be a cause for this disagreement between studies. 
A study conducted with a larger sample with groups featuring 
varying durations of disease could help.
PDUS seems to be an important and promising tool for the 
evaluation of enthesitis. However, PDUS still lacks a consensus on 
the definitions of enthesitis using US to support the method as a 
reference for the diagnosis and treatment of patients with peripheral 
spondyloarthropathies (1).
Two studies have highlighted the use of PD in inflammatory 
disease to diagnose enthesitis. As part of the MASEI, bone erosion 
and PD showed better predictive value for inflammatory enthesitis 
in affected patients than in control participants (17). In 2011, 
D’Agostino et al. (29) demonstrated high predictive value of PD 
for the diagnosis of spondyloarthritis when patients with clinical 
suspicion were evaluated.
The fact that all patients were receiving treatment for at 
least 1.5 years (and many of them for several years) could have 
influenced the low prevalence of PD signals or active inflammation. 
In our study, we identified PD signals in only 8 entheses (1.3%), 
in contrast to previous data obtained by D’Agostino et al. (16), who 
found a PD signal in 81% of evaluated entheses, and de Miguel et al. 
(17), who found 60% positivity. The low prevalence of PD signals 
was also observed by Spadaro et al. (30), who found these signals 
in only 5% of participants; similar to our data, 58% of patients 
were using anti-TNFα drugs, which could have influenced the low 
vascularization in entheses because these drugs are responsible for 
blocking an important inflammatory pathway.
Table 3 - Continuation
Triceps Brachii Calcification 0.337
0 72 (72) 50 (83.3)
1 10 (10) 5 (8.3)
2 16 (16) 4 (6.7)
3 2 (2) 1 (1.7)
Erosion 0 1 (1.7) 0.375
Power Doppler signal 0 0 1.000
Thickening 70 (70) 41 (68.3) 0.825
Structural change 7 (7) 2 (3.3) 0.331
ASG: ankylosing spondylitis group; CG: control group; OR: odds ratio for belonging to the AS group. The χ2 and Fisher tests were used.
Table 4 - Concordance indices for quantitative variables (US 
Evaluation of Tendon Thickness) for Assessing Interobserver 
Agreement.
Tendon ICC (p)
Minimum and 
Maximum
Brachial triceps 0.968 (0.000) 0.909 to 0.989
Distal quadriceps 0.971 (0.000) 0.917 to 0.990
Proximal patellar 
tendon
0.987 (0.000) 0.961 to 0.995
Distal patellar tendon 0.975 (0.000) 0.789 to 0.994
Achilles tendon 0.990 (0.000) 0.970 to 0.997
Plantar fascia 0.970 (0.000) 0.916 to 0.990
ICC: Intraclass correlation coefficient.
Table 5 - Cohen’s Kappa Correlation for Semiquantitative 
Measures in the Interobserver Analysis.
Ultrasound variable Enthesis Cohen’s Kappa (p)
Calcification Triceps brachii 0.750 (0.000)
Quadriceps femoralis 0.895 (0.000)
Proximal patellar tendon 1.000 (0.000)
Distal patellar tendon 1.000 (0.000)
Calcaneal or Achilles 1.000 (0.000)
Plantar fascia 1.000 (0.000)
Bursitis Distal patellar tendon 1.000 (0.000)
Calcaneal 1.000 (0.000)
Bone erosion Triceps brachii 1.000 (0.000)
Quadriceps femoralis 1.000 (0.000)
Proximal patellar tendon 1.000 (0.000)
Distal patellar tendon 1.000 (0.000)
Calcaneal or Achilles 1.000 (0.000)
Plantar fascia 1.000 (0.000)
Power Doppler signal Triceps brachii 1.000 (0.000)
Quadriceps femoralis 1.000 (0.000)
Proximal patellar tendon 1.000 (0.000)
Distal patellar tendon 1.000 (0.000)
Calcaneal or Achilles 1.000 (0.000)
Plantar fascia 1.000 (0.000)
Structural change Triceps brachii 1.000 (0.000)
Quadriceps femoralis 0.385 (0.051)
Proximal patellar tendon 1.000 (0.000)
Distal patellar tendon 1.000 (0.000)
Calcaneal or Achilles 1.000 (0.000)
Plantar fascia 1.000 (0.000)
Thickening Triceps brachii 0.600 (0.009)
Quadriceps femoralis 0.818 (0.001)
Proximal patellar tendon 1.000 (0.000)
Distal patellar tendon 0.862 (0.000)
Calcaneal or Achilles 0.862 (0.000)
Plantar fascia 1.000 (0.000)
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Other authors, who assessed PDUS in heels using MRI as the 
reference standard, reported no specific findings of inflammatory 
disease in affected patients compared with control participants 
without inflammatory disease (31). Furthermore, during the 
evaluation of painful heels in patients with spondyloarthritis 
stemming from a traumatic injury, no findings were specific for 
spondyloarthritis (19). These data contradict our findings, which 
identified bone erosion and PD signals only in the calcaneal 
entheses of patients.
Calcification or enthesophyte formation in the quadriceps 
enthesis was presented as a risk factor for AS, indicating a five 
times higher risk of a lesion due to inflammatory disease. This 
was the first study to identify the importance of the quadriceps 
enthesis for differentiating patients with AS from healthy subjects. 
The changes described are considered by some authors to indicate 
chronic enthesitis (1,7) and might be related to long-standing 
disease. While this finding is not helpful for the early diagnosis 
of the disease, it could help in cases of diagnostic doubt and in 
classifying patients. Therefore, we believe that studies that help 
to standardize which locations are used to evaluate AS, as well as 
which lesions should be considered, will be valuable and should be 
encouraged. We also believe that the quadriceps enthesis should 
receive greater attention in future evaluations, given the possibility 
that this enthesis can be used to help identify characteristic lesions 
of AS and assist in diagnosis.
Our study had limitations. The number of patients and 
control individuals assessed, although calculated, may have been 
insufficient to demonstrate differences in US evaluation findings 
between the groups. It was not possible to perform logistic 
regression analysis between the groups for the bone erosion in the 
calcaneus and plantar fascia. In both cases, no healthy individuals 
had these lesions, making application of a statistical test impossible.
The present study demonstrated that, when applied by trained 
evaluators, PDUS may have good to excellent interobserver 
agreement. Therefore, US can be a very useful tool for assessing 
entheses in patients with AS because this modality is a safe imaging 
method that requires no radiation exposure or contrast material; 
furthermore, US is fast to perform and inexpensive when compared 
with MRI.
The presence of US findings (bone erosions) in the heel (entheses 
of the calcaneal tendon and plantar fascia) was an important 
characteristic that differentiated patients with long-standing AS 
from healthy controls. However, increased thickness of the plantar 
fascia and calcification of the quadriceps enthesis in our study were 
the only parameters that showed an OR that identified patients as 
belonging to the ASG, and we believe that analysis of these specific 
entheses should be performed more than it is currently.
We conclude that bone erosion in the calcaneal enthesis 
(tendons and fascia), thickening of the plantar fascia, and, 
calcification in the quadriceps enthesis are US findings that can 
differentiate patients with AS from healthy controls. The total 
MASEI score was not able to differentiate patients with AS from 
healthy individuals in this study.
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